Przejdź do treści
Central European Journal of Sport Sciences and Medicine
Vol. 49, No. 1/2025
Statystyki OpenAlex

Dla całego czasopisma, według OpenAlex.

Cytowania
1 077
Publikacje
412
H-index
12
I10-index
22
Średnia cytowań (2 lata)
0,43
Cytowania w poszczególnych latach
Wykres cytowań czasopisma. Dokładne wartości są dostępne w tabeli poniżej. 2017: 37 2018: 45 2019: 56 2020: 112 2021: 106 2022: 146 2023: 150 2024: 161 2025: 132 2026: 67 2017 2026
Pokaż dane w tabeli
Cytowania w poszczególnych latach
RokPublikacjeCytowania
20174237
20183345
20193556
202038112
202138106
202231146
202330150
202429161
202530132
20261667

Dane pobrane:

Co oznaczają te liczby?

Publikacje i cytowania obejmują rekordy powiązane z tym czasopismem w OpenAlex. H-index to największa liczba h publikacji mających co najmniej h cytowań. I10-index to liczba publikacji cytowanych co najmniej 10 razy. Wykres przedstawia cytowania otrzymane w danym roku; bieżący rok jest niepełny. Zakres bazy może różnić się od WNUS i innych serwisów.

Średnia z 2 lat jest wskaźnikiem OpenAlex. Nie jest to Journal Impact Factor firmy Clarivate.

Zobacz w OpenAlex (nowa karta)

Investigating Nutritional and Health Dynamics across Stratified Profiles of Obesity

DOI: 10.18276/cej.2025.1-02
Cytuj

Pełny tekst jest dostępny

ISSN:2300-9705
eISSN:2353-2807
Autorzy: Martina Gažarová ORCID
Faculty of Agrobiology and Food Resources, Slovak University of Agriculture in Nitra, Slovakia

Stanislav Azor ORCID
Technical University in Zvolen (Institute of Physical Education and Sports)

Petra Lenártová ORCID
Faculty of Agrobiology and Food Resources, Slovak University of Agriculture in Nitra, Slovakia

Karin Baisová ORCID
Institute of Physical Education and Sports, Technical University in Zvolen, Slovakia
Słowa kluczowe: Anthropometry lipid profile metabolic health nutrition obesity.
Data publikacji całości:2025-07-31
Liczba stron:14 (19-32)
OAI-PMH:Metadane
Klasyfikacja JEL: I10
Cited-by (Crossref) ?: Włącz JavaScript, aby pobrać dane cytowań.
CC BY-SA Open Access DOAJ Scopus Diamond Discovery Hub
Kod QR

Abstrakt

The study investigates metabolically healthy obesity (MHO), a subgroup of obese individuals seemingly protected from cardiometabolic diseases. The lack of a standardized definition for MHO has led to variations in classification criteria. The research, involving 263 participants (64 meeting obesity criteria), assessed body composition using multi-frequency bioimpedance and determined biochemical parameters with Biolis 24i Premium. Statistical analysis employed STATISTICA 13 and MedCalc, with significance set at p < .05. Despite metabolically healthy subjects displaying elevated anthropometric values, their biochemical and somatic parameters remained within normal ranges. Surprisingly, a healthier metabolic profile did not correlate with reduced mortality risk. The study highlights the significant impact of different MHO definitions on prevalence estimates within the same population. Stricter criteria yielded lower prevalence, while broader criteria, such as a higher BMI plus one critical parameter, resulted in higher prevalence. Using various parameter combinations, the study identified MHO subjects, revealing significant differences in triglycerides, systolic, and diastolic blood pressure between MHO groups (p < .05). For instance, based on BMI and HDL, 56 subjects were identified, while BMI and TAG identified 38 subjects. The findings emphasize the necessity of considering all diagnostic criteria when diagnosing MHO. The study cautions against viewing MHO as a state of complete health, especially given the multifaceted health risks associated with obesity, encompassing cardiovascular, metabolic, orthopedic, dermatological, psychological, and other conditions. The research underlines the importance of accurate MHO classification in understanding its implications and underscores the need for a standardized definition in future studies to facilitate meaningful comparisons across diverse populations.

PDF

Pobierz PDF
Podgląd PDF

Otwórz PDF

Bibliografia (44)
  1. Achilike I, Hazuda HP, Fowler SP, Aung K, Lorenzo C. Predicting the development of the metabolically healthy obese phenotype. Int J Obes. 2015;39(2): 228-234. DOI: 10.1038/ijo.2014.113
  2. Adamčák Š, Bartík P, Marko M. Physical activity of Slovak adolescents during the “Second Wave” of Covid-19 pandemic: Cross-sectional study. Eur J Contemp Educ. 2022;11(4): 1066-1078. DOI: 10.13187/ejced.2022.4.1066
  3. Adamčák Š, Marko M, Bartík P. Physical (in)activity gender gap of Slovak non-athlete adolescents. Phy Educ Theory Methodol. 2022;23(2): 283-289. DOI: 10.17309/tmfv.2023.2.18
  4. Appleton, S.L., Seaborn, C.J., Visvanathan, R., Hill, C.L., Gill, T.K., Taylor, A.W., Adams, R.J., North West Adelaide Health Study Team. (2013). Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36(8), 2388-2394. DOI: 10.2337/dc12-1971.
  5. Bosy-Westphal A, Müller MJ. Diagnosis of obesity based on body composition-associated health risks-Time for a change in paradigm. Obes Rev. 2021;22(2): e13190. DOI: 10.1111/obr.13190
  6. Bray GA, Kim KK, Wilding JPH. World Obesity Federation. Obesity: Chronic relapsing progressive disease process. Obes Rev. 2017;18(7): 715-723. DOI: 10.1111/obr.12551
  7. Brown RE, Sharma AM, Ardern CI, Mirdamadi P, Mirdamadi P, Kuk J. Secular differences in association between caloric intake, macronutrient intake, and physical activity with obesity. Obes Res Clin Pract. 2016;10(3): 243-255. DOI: 10.1016/j.orcp.2015.08.007
  8. Chen DL, Liess C, Poljak A, Xu A, Zhang J, Thoma C, Trenell M, Milner B, Jenkins AB, Chisholm DJ, Samocha-Bonet D, Greenfield JR. Phenotypic characterization of insulin-resistant and insulin-sensitive obesity. J Clin Endocrinol Metab. 2015;100(11): 4082-4091. DOI: 10.1210/jc.2015-2712
  9. Cherqaoui R, Kassim TA, Kwagyan J, Freeman C, Nunlee-Bland G, Ketete M, Xu S, Randall OS. The metabolically healthy but obese phenotype in African Americans. J Clin Hypertens. 2012;14(2): 92-96. DOI: 10.1111/j.1751-7176.2011.00565.x
  10. Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92(1): 6-10. DOI: 10.1016/j.metabol.2018.09.005
  11. Clinical practice guidelines for the management of overweight and obesity in adults. Canberra: National Health and Medical Research Council (2013). Available on: https://www.nhmrc.gov.au/aboutus/publications/clinicalpracticeguidelinesmanagementoverweight-and-obesity (14.12.2022).
  12. Echouffo-Tcheugui JB, Short MI, Xanthakis V, Field P, Sponholtz TR, Larson MG, Vasan RS. Natural history of obesity subphenotypes: Dynamic changes over two decades and prognosis in framingham heart study. J Clin Endocrinol Metab. 2019;104(3): 738-752. DOI: 10.1210/jc.2018-01321
  13. Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6(9): 714-724. DOI: 10.1016/S2213-8587(18)30137-2
  14. Fabbrini, E., Cella, M., McCartney, S.A., Fuchs, A., Abumrad, N.A., et al. (2013). Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology. 145(2),366–74.e743. DOI: 10.1053/j.gastro.2013.04.010
  15. Gažarová M, Bihari M, Lorková M, Lenártová P, Habánová M. Use of different anthropometric indices to assess the body composition of young women in relation to icidence of obesity, sarcopenia and the premature mortality risk. Int J Environ Res Public Health. 2022;19:12449. DOI: 10.3390/ijerph191912449
  16. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012;97(7): 2482-2488. DOI: 10.1210/jc.2011-3475
  17. Hill JO, Wyatt HR. Myth of healthy obesity. Ann Intern Med. 2013;159(11): 789-790. DOI: 10.7 326/0003-4819-159-11-201312030-00016
  18. Janiszewski PM, Ross R. Effects of weight loss among metabolically healthy obese men and women. Diabetes Care. 2010;33(9): 1957-1959. DOI: 10.2337/dc10-0547
  19. Kantartzis K, Machann J, Schick F, Rittig K, Machicao F, Fritsche A, Häring H, Stefan N. Effects of lifestyle intervention in metabolically benign and malign obesity. Diabetologia. 2011;54(4): 864-868. DOI: 10.1007/s00125-010-2006-3
  20. Klöting N, Fasshauer M, Dietrich A, Kovacs P, Schön MR, Kern M, Stumvoll M, Blüher M. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab. 2010;299(3): 506-515. DOI: 10.1152/ajpendo.00586.2009
  21. Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, Kanaya AM, Visser M, Houston DK, Nicklas B, Tylavsky A, Satterfield S, Goodpaster H, Ferrucci L, Harris B. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity. 2010;18(12): 2354-2361. DOI: 10.1038/oby.2010.86
  22. Krakauer NY, Krakauer JC. New body shape index predicts mortality hazard independently of body mass index. Plos One. 2012;7(7): e39504 .DOI: 10.1371/journal.pone.0039504
  23. Krakauer NY, Krakauer JC. Dynamic association of mortality hazard with body shape. Plos One. 2014; 9(2): e88793. DOI: 10.1371/journal.pone.0088793
  24. Ladabaum U, Mannalithara A, Myer PA, Singh G. Obesity, abdominal obesity, physical activity, and caloric intake in US adults: 1988 to 2010. Am J Med. 2014;127(8): 717-727. DOI: 10.1016/j.amjmed.2014.02.026
  25. Lavie CJ, Deedwania P, Ortega FB. Obesity is rarely healthy. Lancet Diabetes Endocrinol. 2018; 6(9): 678-679. DOI: 10.1016/S2213-8587(18)30143-8
  26. Lavie CJ, Laddu D, Arena R, Ortega FB, Alpert A, Kushner RF. Healthy weight and obesity prevention: Health Promotion Series. J Am Coll Cardiol. 2018;72(13): 1506-1531. DOI: 10.1016/j.jacc.2018.08.1037
  27. Lin H, Zhang L, Zheng R, Zheng Y. The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: Systematic review and meta-analysis: Prisma-compliant article. Medicine. 2017;96(47): 888. DOI: 10.1097/MD.0000000000008838
  28. Liu C, Wang C, Guan S, Liu H, Wu X, Zhang Z, Gu X, Zhang Y, Zhao Y, Tse L, Fang X. Prevalence of metabolically healthy and unhealthy obesity according to different criteria. Obes Facts. 2019;12(1): 78-90. DOI: 10.1159/000495852
  29. Magkos F. Metabolically healthy obesity: what's in a name?. Am J Clin Nutr. 2019;110(3): 533-539. DOI: 10.1093/ajcn/nqz133
  30. Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly SC, de las Fuentes L, He S, Okunade AL, Patterson BW, Klein S. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 2016;23(4): 591-601. DOI: 10.1016/j.cmet.2016.02.005
  31. Mongraw-Chaffin M, Foster MC, Anderson C, Burke GL, Haq N, Kalyani R, Ouyang P, Sibley T, Tracy R, Woodward M. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2018;71(17): 1857-1865. DOI: 10.1016/j.jacc.2018.02.055
  32. NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: Pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026): 1377-1396. DOI: 10.1016/S0140-6736(16)30054-X
  33. NCD Risk Factor Collaboration. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: Pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113): 2627-2642. DOI: 10.1016/S0140-6736(17)32129-3.
  34. Pluta W, Dudzińska W, Lubkowska A. Metabolic obesity in people with normal body eeight - Review of diagnostic criteria. Int J Environ Res Public Health. 2022;19(2): 624. DOI: 10.3390/ijerph19020624
  35. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, Sladek R, Rabasa-Lhoret R. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes. 2011;35(7): 971-981. DOI: 10.1038/ijo.2010.216
  36. Rey-López JP, de Rezende LF, Pastor-Valero M, Tess BH. Prevalence of metabolically healthy obesity: Systematic review and critical evaluation of definitions used. Obes Rev. 2014;15(10): 781-790. DOI: 10.1111/obr.12198
  37. Ruiz JR, Ortega FB, Labayen I. A weight loss diet intervention has a similar beneficial effect on both metabolically abnormal obese and metabolically healthy but obese premenopausal women. Ann Nutr Metab. 2013;62(3): 223-230. DOI: 10.1159/000345026
  38. Sjöström L. Review of key results from Swedish obese subjects trial - Prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3): 219-234. DOI: 10.1111/joim.12012
  39. Skrzypczak M, Szwed A, Pawlińska-Chmara R, Skrzypulec V. Assessment of BMI, WHR and W/Ht in pre- and post-menopausal women. Anthropol. Rev. 2007; 70(1): 3-13.
  40. Stefan N, Schick F, Häring H. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26(2): 292-300. DOI: 10.1016/j.cmet.2017.07.008
  41. Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, Gale CP, Achenbach S, Weidinger F, Vardas P. Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol. 2022;19 (2): 133-143. DOI: 10.1038/s41569-021-00607-3
  42. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, Gaye A, Gögele M, Heier M, Hiekkalinna T, Joensuu A, Newby C, Pang C, Partinen E, Reischl E, Schwienbacher C, Swertz MA, Tammesoo ML, Burton P, Ferretti V, Fortier I, Giepmans L, Harris JR, Hillege HL, Holmen J, Jula A, Kootstra-Ros JE, Kvaløy K, Holmen TL, Männistö S, Metspalu A, Midthjell K, Murtagh MJ, Peters A, Pramstaller PP, Saaristo T, Salomaa V, Stolk RP, Uusitupa M, van der Harst P, van der Klauw MM, Waldenberger M, Perola M, Wolffenbuttel BHR. Prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014; 14(1): 9. DOI: 10.1186/1472-6823-14-9
  43. Vogel M, Geserick M, Gausche R, Beger C, Poulain T, Meigen C, Körner A, Keller E, Kiess W, Pfäffle R. Age- and weight group-specific weight gain patterns in children and adolescents during the 15 years before and during the Covid-19 pandemic. Int J Obes. 2022;46(1): 144-152. DOI: 10.1038/s41366-021-00968-2
  44. World Health Organisation. European Regional Obesity Report. Copenhagen: WHO Regional Office for Europe; 2022. Licence: CC BY-NC-SA 3.0 IGO.